CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
University of Florence
Florencia, ItaliaPublicaciones en colaboración con investigadores/as de University of Florence (23)
2024
-
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
Journal of neurology, Vol. 271, Núm. 1, pp. 472-485
2023
-
European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
European Journal of Neurology, Vol. 30, Núm. 8, pp. 2144-2176
-
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
Brain : a journal of neurology, Vol. 146, Núm. 11, pp. 4633-4644
2022
-
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021
Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 28, Núm. 9, pp. 1424-1456
2021
-
Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis
Neurology, Vol. 96, Núm. 24, pp. E2989-E3002
2018
-
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop
Multiple Sclerosis Journal, Vol. 24, Núm. 5, pp. 590-603
-
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis
Multiple Sclerosis Journal, Vol. 24, Núm. 5, pp. 642-652
2017
-
Contribution of different relapse phenotypes to disability in multiple sclerosis
Multiple Sclerosis, Vol. 23, Núm. 2, pp. 266-276
-
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 88, Núm. 3, pp. 196-203
-
Towards personalized therapy for multiple sclerosis: Prediction of individual treatment response
Brain, Vol. 140, Núm. 9, pp. 2426-2443
2016
-
Defining secondary progressive multiple sclerosis
Brain, Vol. 139, Núm. 9, pp. 2395-2405
-
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 87, Núm. 12, pp. 1343-1349
2015
-
BREMSO: A simple score to predict early the natural course of multiple sclerosis
European Journal of Neurology, Vol. 22, Núm. 6, pp. 981-989
-
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis
Multiple Sclerosis, Vol. 21, Núm. 9, pp. 1159-1171
-
Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS
PLoS ONE, Vol. 10, Núm. 6
-
Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry
Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 1
-
Predictors of disability worsening in clinically isolated syndrome
Annals of Clinical and Translational Neurology, Vol. 2, Núm. 5, pp. 479-491
2014
-
Predictors and dynamics of postpartum relapses in women with multiple sclerosis
Multiple Sclerosis Journal, Vol. 20, Núm. 6, pp. 739-746
-
Seasonal variation of relapse rate in multiple sclerosis is latitude dependent
Annals of Neurology, Vol. 76, Núm. 6, pp. 880-890
2013
-
Clinical case reviews in multiple sclerosis spasticity: Experiences from around Europe
Expert Review of Neurotherapeutics